NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報

【英語タイトル】NovaBay Pharmaceuticals Inc (NBY) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7370)・商品コード:DATA904C7370
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:37
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris on and around the lid and eyelid margins. NovaBay develops aganocide compound through research and development based on the human body’s natural immune system and molecules involved in combating infections. The company’s products find application in therapeutic areas such as ophthalmology, wound care, dermatology, and neutrophase. It partners with pharmaceutical and biotech companies. NovaBay is headquartered in Emeryville, California, the US.

NovaBay Pharmaceuticals Inc (NBY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NovaBay Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 10
Equity Offering 11
NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 11
NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 12
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 13
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 14
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 15
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 16
Acquisition 17
Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 17
NovaBay Pharmaceuticals Inc – Key Competitors 18
NovaBay Pharmaceuticals Inc – Key Employees 19
NovaBay Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2018: Novabay Pharmaceuticals announces second quarter 2018 financial results 21
May 10, 2018: NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results 23
Mar 20, 2018: NovaBay Pharmaceuticals Announces 2017 Fourth Quarter And Full Year Financial Results 24
Jan 08, 2018: NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year 26
Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results 27
May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results 29
Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance 31
Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016 33
Corporate Communications 34
Jul 05, 2018: NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth 34
Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition 35
Legal and Regulatory 36
Dec 21, 2017: NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
NovaBay Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 10
NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 11
NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 12
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 13
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 14
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 15
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 16
Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 17
NovaBay Pharmaceuticals Inc, Key Competitors 18
NovaBay Pharmaceuticals Inc, Key Employees 19

List of Figures
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7370)販売に関する免責事項を必ずご確認ください。
★調査レポート[NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆